Familial hypertriglyceridaemia

3 trials MedDRA PT
3 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 3

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

3 trials
  • Ionis Pharmaceuticals Inc. Commercial
    ISIS 678354 SODIUM SALT
    2022-501420-20-00 15 countries 2023 n=248
    Ended
  • Ionis Pharmaceuticals Inc. Commercial
    ISIS 678354 SODIUM SALT
    2023-509029-29-00 7 countries 2022 n=30
    Ended
  • Ionis Pharmaceuticals Inc. Commercial
    ISIS 678354 SODIUM SALT
    2024-510696-38-00 15 countries 2022 n=368
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Ionis Pharmaceuticals Inc. Commercial 3 Phase III 0
New trials by year
2022
2
2023
1
← All indication landscapes